Ochre Bio’s $37.5 Million License Agreement with GSK

Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction.Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a multi-year…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here